This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...